Tag: AI Act

Browse our exclusive articles!

OpenAI’s Influence on E.U.’s AI Legislation Revealed

Learn how OpenAI, alongside other tech giants, has been lobbying for amendments to the EU's AI Act, potentially reducing regulatory burden on companies like OpenAI and undermining the Act's aim to balance innovation and safety.

OpenAI successfully lobbied to weaken EU’s AI Act, avoiding high-risk classification for general purpose AI

OpenAI is facing accusations of watering down parts of the EU's AI Act to avoid being deemed high risk. Learn more about their alleged lobbying efforts and the controversy surrounding regulation of AI in Europe.

Oracle Launches Sovereign Cloud for European Customers

Oracle's new cloud service for EU customers addresses data sovereignty concerns and is available to any organization. With GDPR and upcoming laws, digital sovereignty is increasingly important. Backed by two data centres in Germany and Spain, customer data is controlled by separate legal entities in the EU.

OpenAI Pushes for Less Stringent AI Regulations in Europe

OpenAI reportedly lobbied for the European Union's AI Act to be watered down, excluding their systems from high-risk designation. Successful lobbying revealed.

The Pros and Cons of UK’s Early Access to OpenAI and DeepMind Models

UK PM Rishi Sunak announced early or priority access to AI models by Google DeepMind, OpenAI, and Anthropic. This move will aid research and safety efforts in understanding opportunities and risks of these systems in healthcare, education, and public services. The UK wants to become the best in tech globally, investing £100m in a designated AI taskforce. However, involving private companies in the conversation poses risks that could influence safety approaches around their tech. The UK will host the first-ever Global Summit on AI Safety later this year.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img